A predictive survival model for patients with head and neck squamous cell carcinoma treated with immune check point inhibitors

被引：6
|
作者：
Bonomi, M. [1 ]
Bhateja, P. [1 ]
Issa, M. [1 ]
Klamer, B. [2 ]
Pan, X. [2 ]
Blakaj, A. [3 ]
Karivedu, V [1 ]
Mousa, L. [1 ]
Mitchell, D. [5 ]
Gamez, M. [5 ]
Kang, S. [4 ]
Seim, Nolan B. [4 ]
Old, M. [4 ]
Carrau, R. [4 ]
Rocco, J. [4 ]
Blakaj, D. [5 ]
机构：
[1] Ohio State Univ, Div Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA
[3] Yale Univ, Div Radiat Oncol, New Haven, CT USA
[4] Ohio State Univ, Div Otolaryngol, Columbus, OH 43210 USA
[5] Ohio State Univ, Div Radiat Oncol, Columbus, OH 43210 USA
来源：
ORAL ONCOLOGY | 2020年 / 110卷
关键词：
PD-1; inhibitors; Metastatic; Head and neck cancer; Response; Predictors; Immunotherapy; CANCER; IMMUNOTHERAPY; NIVOLUMAB; RECURRENT; INDEX;
D O I：
10.1016/j.oraloncology.2020.104900
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: ICIs have expanded treatment options for HNSCC. A minority of the patients respond to these expensive treatments. Patients and methods: This is a single institutional retrospective review on 121 unresectable or metastatic HNSCC patients treated with ICIs. We predicted that inflammatory markers available through routine blood work, in addition to clinical characteristics may divide patients into groups more or less likely to respond to these agents. Here we develop and internally validate our nomogram to predict survival in patients treated with ICIs.
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Papaxoinis, George
    Gavrielatou, Niki
    Anastasiou, Maria
    Pantazopoulos, Anastasios
    Kavourakis, George
    Gkolfinopoulos, Stavros
    Panayiotides, Ioannis
    Delides, Alexandros
    Psyrri, Amanda
    ORAL ONCOLOGY, 2020, 111
  • [32] Has Survival for Patients with Squamous Cell Carcinoma of the Head and Neck Treated with Radiotherapy Improved Over Time?
    Abramowitz, M. C.
    Santos, E.
    Raez, L.
    Weed, D.
    Mahmoud, O.
    Sperry, J.
    Wright, J.
    Sargi, Z.
    Lally, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S426 - S426
  • [33] Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
    Park, Jong Chul
    Krishnakumar, Hari N.
    Saladi, Srinivas Vinod
    CURRENT ONCOLOGY, 2022, 29 (06) : 4185 - 4198
  • [34] PDE5 inhibitors for the immune therapy of head and neck squamous cell carcinoma
    Serafini, P.
    Weed, D.
    Vella, J.
    Delafuente, A.
    Gomez, C. R.
    Rodriguez, Z.
    Walker, G.
    IMMUNOLOGY, 2012, 137 : 719 - 719
  • [35] Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival
    Lien, Ming-Yu
    Wang, Ti-Hao
    Hsieh, Ching-Yun
    Tsai, Ming-Hsui
    Hua, Chun-Hung
    Cheng, Fu-Ming
    Chung, Wen-Hui
    Tang, Chih-Hsin
    Hsieh, Jason Chia-Hsun
    ORAL ONCOLOGY, 2021, 119
  • [36] Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell Carcinoma
    Mastrolonardo, Eric V.
    Llerena, Pablo
    Lu, Joseph
    Nunes, Kathryn
    Choi, Grace K.
    Amin, Dev
    Bridgham, Kelly M.
    Campbell, Daniel
    Philips, Ramez
    Cognetti, David M.
    Luginbuhl, Adam J.
    Curry, Joseph M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2024,
  • [37] A predictive survival model for patients with stage IV oropharyngeal squamous cell carcinoma treated with chemoradiation
    Peng Yeh
    Chih-Ming Chang
    Li-Jen Liao
    Chia-Yun Wu
    Chen-Hsi Hsieh
    Pei-Wei Shueng
    Po-Wen Cheng
    Wu-Chia Lo
    European Archives of Oto-Rhino-Laryngology, 2024, 281 : 369 - 377
  • [38] A predictive survival model for patients with stage IV oropharyngeal squamous cell carcinoma treated with chemoradiation
    Yeh, Peng
    Chang, Chih-Ming
    Liao, Li-Jen
    Wu, Chia-Yun
    Hsieh, Chen-Hsi
    Shueng, Pei-Wei
    Cheng, Po-Wen
    Lo, Wu-Chia
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (01) : 369 - 377
  • [39] Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
    Liu, Xingyu
    Chen, Jiarui
    Lu, Wei
    Zeng, Zihang
    Li, Jiali
    Jiang, Xueping
    Gao, Yanping
    Gong, Yan
    Wu, Qiuji
    Xie, Conghua
    FRONTIERS IN GENETICS, 2020, 11
  • [40] Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck
    Saleh, Khalil
    Auperin, Anne
    Martin, Nicolas
    Borcoman, Edith
    Torossian, Nouritza
    Iacob, Mariana
    Ferrand, Francois-Regis
    Khalife, Nadine
    Baste, Neus
    Guigay, Joel
    Le Tourneau, Christophe
    Daste, Amaury
    Saada-Bouzid, Esma
    Even, Caroline
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 190 - 197
12345